Differential glycemic effects of DWP16001 in diabetic dogs according to baseline glycemic status: a multicenter randomized controlled trial
DWP16001 is a safe and effective adjunct to insulin therapy for diabetic dogs, especially those with suboptimal glycemic control. It demonstrated insulin-sparing effects and favorable metabolic safety, necessitating further evaluation in long-term clinical studies.
Authors
- Hyun‐Woo Lim (ORCID: https://orcid.org/0000-0001-6013-8106)
- Wan Huh (ORCID: https://orcid.org/0000-0001-7272-4946)
- Min‐Ok Ryu (ORCID: https://orcid.org/0000-0002-5614-9846)
- Hwa‐Young Youn (ORCID: https://orcid.org/0000-0002-0283-1348)
- Ben C.B. Ko (ORCID: https://orcid.org/0000-0003-2027-5899)
- Ju‐Hyun An (ORCID: https://orcid.org/0000-0002-3756-9482)
- Joon Seok Park (ORCID: https://orcid.org/0000-0003-4001-6886)
- H. Lee
- Jae‐Bong Moon
- H. Namkung
Institutions
- Seoul National University (KR)
- Kangwon National University (KR)
- New Generation University College (ET)
- Daewon Pharm (South Korea) (KR)
- Daewoong Pharmaceutical (South Korea) (KR)
Publication Details
- Journal
- BMC Veterinary Research
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1186/s12917-025-04962-y
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Seoul National University
- Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University